CARDIFF ONCOLOGY, INC. Increase (Decrease) in Other Operating Liabilities
CARDIFF ONCOLOGY, INC. (CRDF) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-02-29
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for fiscal 2023 was $0.00.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for fiscal 2022 was -$42.00K.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$156.00K, a 322.86% decline from fiscal 2020.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating liabilities for fiscal 2020 was $70.00K, a 18.95% decline from fiscal 2019.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | -$8.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$8.00K derived: sum of 3 quarters · filed 2024-02-29 | -$10.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | -$8.00K derived: sum of 2 quarters · filed 2024-02-29 | -$10.00K derived: sum of 3 quarters · filed 2024-02-29 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$10.00K derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | -$42.00K 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $8.00K derived: sum of 2 quarters · filed 2023-11-02 | -$34.00K 10-Q · filed 2023-11-02 | -$64.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$32.00K 10-Q · filed 2023-08-09 | -$62.00K derived: sum of 3 quarters · filed 2023-08-09 | -$246.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$42.00K 10-Q · filed 2023-05-04 | -$72.00K derived: sum of 2 quarters · filed 2023-05-04 | -$256.00K derived: sum of 3 quarters · filed 2023-05-04 | -$232.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$214.00K derived: sum of 2 quarters · filed 2023-03-02 | -$190.00K derived: sum of 3 quarters · filed 2023-03-02 | -$156.00K 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | -$184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$160.00K derived: sum of 2 quarters · filed 2022-11-03 | -$126.00K 10-Q · filed 2022-11-03 | -$16.00K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $58.00K 10-Q · filed 2022-08-04 | $168.00K derived: sum of 3 quarters · filed 2022-08-04 | $184.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $34.00K 10-Q · filed 2022-05-05 | $144.00K derived: sum of 2 quarters · filed 2022-05-05 | $160.00K derived: sum of 3 quarters · filed 2022-05-05 | $93.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $126.00K derived: sum of 2 quarters · filed 2022-02-24 | $59.00K derived: sum of 3 quarters · filed 2022-02-24 | $70.00K 10-K · filed 2022-02-24 | $69.90K 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$51.00K derived: sum of 2 quarters · filed 2021-11-04 | -$40.00K 10-Q · filed 2021-11-04 | -$39.92K 10-Q · filed 2020-11-05 | $46.37K derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$56.00K 10-Q · filed 2021-08-05 | -$55.67K 10-Q · filed 2020-08-11 | $30.37K derived: sum of 3 quarters · filed 2021-08-05 | $30.37K derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-06 | $10.68K 10-Q · filed 2020-05-07 | $97.37K derived: sum of 2 quarters · filed 2021-05-06 | $97.37K derived: sum of 3 quarters · filed 2021-05-06 | $97.37K derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $86.37K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $86.37K derived: sum of 2 quarters · filed 2021-02-25 | $86.37K derived: sum of 3 quarters · filed 2021-02-25 | $86.37K 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $22.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |